为帕金森病患者实施药剂师领导的药物审查服务 患者被录取用于深度大脑刺激

Ugene Sano1, Timothy Jacisin1, Jessica Bente1

  • 1Cooperman Barnabas Medical Center, Livingston, New Jersey.

PubMed
概括

一项由药剂师主导的药物审查显著增加了家庭帕金森病后深度大脑刺激 (DBS) 方案的重新启动率. 这次干预发现了DBS手术后不适当使用多巴胺抗剂的一例.

相关概念视频

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
547